Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrates and dialysis kits, and sells, distributes and delivers such concentrates and dialysis kits, as well as other ancillary hemodialysis products, to hemodialysis providers in the United States. Hemodialysis is a process which is able to duplicate kidney function in patients whose kidneys have failed to function properly.
Info & Links
CEO
Mark Strobeck
Headquarters
30142 S. WIXOM ROAD WIXOM, MI 48393, UNITED STATES
Rockwell Medical, Inc. (DE) Common Stock Statistics
Valuation Measures
Market Capitalization2
32.72M
Enterprise Value
31.27M
Enterprise Value/EBITDA(ttm)
6.25
Price to Earnings Ratio(ttm)
30.00
Price to Sales(ttm)
0.59
Price to Book(mrq)
1.92
Price to Cash(ytd)
92.73
Profitability
Gross Margin(ttm)
17.61%
Operating Margin(ttm)
2.04%
Profit Margin(ttm)
-0.97%
Return on Equity(ttm)
8.55%
Return on Invested Capital(ttm)
-0.16%
Return on Assets(ttm)
3.80%
Income Statement
Revenue(ttm)
97.73M
Revenue Per Share(ttm)
2.86
Gross Profit(ttm)
17.46M
EBITDA(ttm)3
5.00M
Net Income Available to Common(ttm)
-264.00K
Diluted EPS(ttm)
-0.05
Share Statistics
Beta (5Y Monthly)
1.39
52-Week Change
-48.76%
S&P 500 52-Week Change
9.20%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
34.17M
Dividend Yield
0.00%
Float4
31.70M
% Held by Insiders
1.90%
% Held by Institutions
23.31%
Balance Sheet
Total Cash(mrq)
17.33M
Total Cash Per Share(mrq)
0.51
Total Debt(mrq)
9.94M
Total Debt/Equity(mrq)
31.54%
Current Ratio(mrq)
2.95%
Quick Ratio(mrq)
2.00%
Book Value Per Share(mrq)
0.92
Cash Flow
Operating Cash Flow Per Share(ytd)
-0.10
Free Cash Flow(ytd)
-3.55M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.